Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of HPI-guided vs ClearSight-guided vs NIBP-guided Norepinephrine for Blood Pressure Stability During Cesarean Delivery
NCT07883265Not yet recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Oct 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
Randomised, open-label trial of norepinephrine in hypotension (3 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Time-weighted average of hypotension at 30 minutes. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
norepinephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT07883265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07883265.